Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emmanuelle Berger

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
Therapeutic Drug Monitoring|November 16, 2018
Evaluation of Infliximab and Anti-infliximab LISA-TRACKER Immunoassays for the Therapeutic Drug Monitoring of SB2 Infliximab BiosimilarAlexandre Jentzer, Anne-Emmanuelle Berger, Rémi Labetoulle, et al.
International Journal of Molecular Sciences|September 9, 2022
Validation Study of a New Random-Access Chemiluminescence Immunoassay Analyzer i-TRACK10<sup>®</sup> to Monitor Infliximab and Adalimumab Serum trough Levels and Anti-Drug AntibodiesAnne Emmanuelle Berger, Aude Gleizes, Louis Waeckel, et al.
Cancer Gene Therapy|April 5, 2022
ERRα coordinates actin and focal adhesion dynamicsViolaine Tribollet, Catherine Cerutti, Alain Géloën, et al.
Journal of Translational Autoimmunity|March 3, 2025
The antibody repertoire of autoimmune sensory neuronopathies targets pathways of the innate and adaptive immune system. An autoantigenomic approachChristian P Moritz, Yannick Tholance, Nadia Boutahar, et al.
Pharmaceutics|December 31, 2025
Microvesicles from Turmeric Extracts Contain Curcuminoids and Modulate Macrophage Polarization and MigrationStefano Tacconi, Audrey Jalabert, Emmanuelle Berger, et al.
Nutrition and Cancer|April 18, 2014
Leptin induces a proliferative response in breast cancer cells but not in normal breast cellsVirginie Dubois, Thierry Jardé, Laetitia Delort, et al.
Vaccines|April 28, 2023
Prior COVID-19 Immunization Does Not Cause IgA- or IgG-Dependent Enhancement of SARS-CoV-2 InfectionMelyssa Yaugel-Novoa, Blandine Noailly, Fabienne Jospin, et al.
Journal of Clinical Medicine|May 27, 2023
Development of Antibodies to Ustekinumab Is Associated with Loss of Response in Patients with Inflammatory Bowel DiseaseXavier Roblin, Gérard Duru, Konstantinos Papamichael, et al.
Biomedicines|October 27, 2022
Increased Immunity against the Oral Germs <i>Porphyromonas gingivalis</i> and <i>Prevotella intermedia</i> in Different Categories of Juvenile Idiopathic ArthritisFranck Zekre, Rolando Cimaz, Mireille Paul, et al.
Journal of Crohn'S & Colitis|June 4, 2018
Soluble Mucosal Addressin Cell Adhesion Molecule 1 and Retinoic Acid are Potential Tools for Therapeutic Drug Monitoring in Patients with Inflammatory Bowel Disease Treated with Vedolizumab: A Proof of Concept StudyStephane Paul, Nicolas Williet, Thomas Di Bernado, et al.
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
Therapeutic Drug Monitoring|November 16, 2018
Evaluation of Infliximab and Anti-infliximab LISA-TRACKER Immunoassays for the Therapeutic Drug Monitoring of SB2 Infliximab BiosimilarAlexandre Jentzer, Anne-Emmanuelle Berger, Rémi Labetoulle, et al.
International Journal of Molecular Sciences|September 9, 2022
Validation Study of a New Random-Access Chemiluminescence Immunoassay Analyzer i-TRACK10<sup>®</sup> to Monitor Infliximab and Adalimumab Serum trough Levels and Anti-Drug AntibodiesAnne Emmanuelle Berger, Aude Gleizes, Louis Waeckel, et al.
Cancer Gene Therapy|April 5, 2022
ERRα coordinates actin and focal adhesion dynamicsViolaine Tribollet, Catherine Cerutti, Alain Géloën, et al.
Journal of Translational Autoimmunity|March 3, 2025
The antibody repertoire of autoimmune sensory neuronopathies targets pathways of the innate and adaptive immune system. An autoantigenomic approachChristian P Moritz, Yannick Tholance, Nadia Boutahar, et al.
Pharmaceutics|December 31, 2025
Microvesicles from Turmeric Extracts Contain Curcuminoids and Modulate Macrophage Polarization and MigrationStefano Tacconi, Audrey Jalabert, Emmanuelle Berger, et al.
Nutrition and Cancer|April 18, 2014
Leptin induces a proliferative response in breast cancer cells but not in normal breast cellsVirginie Dubois, Thierry Jardé, Laetitia Delort, et al.
Vaccines|April 28, 2023
Prior COVID-19 Immunization Does Not Cause IgA- or IgG-Dependent Enhancement of SARS-CoV-2 InfectionMelyssa Yaugel-Novoa, Blandine Noailly, Fabienne Jospin, et al.
Journal of Clinical Medicine|May 27, 2023
Development of Antibodies to Ustekinumab Is Associated with Loss of Response in Patients with Inflammatory Bowel DiseaseXavier Roblin, Gérard Duru, Konstantinos Papamichael, et al.
Biomedicines|October 27, 2022
Increased Immunity against the Oral Germs <i>Porphyromonas gingivalis</i> and <i>Prevotella intermedia</i> in Different Categories of Juvenile Idiopathic ArthritisFranck Zekre, Rolando Cimaz, Mireille Paul, et al.
Journal of Crohn'S & Colitis|June 4, 2018
Soluble Mucosal Addressin Cell Adhesion Molecule 1 and Retinoic Acid are Potential Tools for Therapeutic Drug Monitoring in Patients with Inflammatory Bowel Disease Treated with Vedolizumab: A Proof of Concept StudyStephane Paul, Nicolas Williet, Thomas Di Bernado, et al.
Pageof 5